Metraipolis › archive › dc_d353169c8a17

The future of rare disease drug development: the rare disease cures accelerator data analytics platform (RDCA-DAP) — Europe PMC PMID:37131052

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37131052
DOI
10.1007/s10928-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-10-08T01:10:46.738Z
SHA-256 of the archived text
0989d087f7ee073178c3bffe7583e55e03841d5d75af20854561b22911ec2f4e
Stable URL of this page
https://metraipolis.com/documento/dc_d353169c8a17

How to cite

The future of rare disease drug development: the rare disease cures accelerator data analytics platform (RDCA-DAP) — Europe PMC PMID:37131052 — Europe PMC (en), https://europepmc.org/article/MED/37131052 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d353169c8a17 (Metraipolis archive dc_d353169c8a17, sha256 0989d087f7ee073178c3bffe7583e55e03841d5d75af20854561b22911ec2f4e)
BibTeX
@misc{dcd353169c8a17,
  title = {The future of rare disease drug development: the rare disease cures accelerator data analytics platform (RDCA-DAP) — Europe PMC PMID:37131052},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37131052},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d353169c8a17; sha256 0989d087f7ee073178c3bffe7583e55e03841d5d75af20854561b22911ec2f4e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/37131052. Agents can read the archived copy with the MCP tool read_document.